Login / Signup

Editorial: switching to tenofovir alafenamide monotherapy is effective and safe for other nucleos(t)ide analogues-treated patients with chronic hepatitis B - author's reply.

Eiichi Ogawa
Published in: Alimentary pharmacology & therapeutics (2022)
Keyphrases
  • hepatitis b virus
  • combination therapy
  • molecular docking
  • open label
  • antiretroviral therapy
  • liver fibrosis
  • structure activity relationship
  • randomized controlled trial
  • clinical trial